Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: Results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study

Radiotherapy and Oncology

Volumn 106, Issue 2, 2013, Pages 210-214

  Melchert, Corinna ^a   Gez, Eliahu ^b   Bohlen, Günther ^a   Scarzello, Giovanni ^c   Koziol, Isaac ^d   Anscher, Mitchell ^e   Cytron, Shmuel ^f   Paz, Adrian ^f   Torre, Taryn ^d   Bassignani, Mathew ^d   Dal Moro, Fabrizio ^e   Jocham, Dieter ^a   Yosef, Rami Ben ^b   Corn, Benjamin W ^b   Kovács, György ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b TASMC   (Israel)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^d VA Urology Richmond   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^f BARZILAI MEDICAL CENTER   (Israel)

Author keywords

OAR dose reduction; Prostate; Rectal dose; Tissue separation

Indexed keywords

ARTICLE; BALLOON; BALLOON DILATATION; BIODEGRADABLE IMPLANT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER SYSTEM; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IMPLANTATION; INTENSITY MODULATED RADIATION THERAPY; INVASIVE PROCEDURE; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PROTECTION; RECTUM; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT PLANNING; VIRTUAL REALITY;

HUMANS; MALE; ORGANS AT RISK; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RECTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84876047912     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.01.007     Document Type: Article

References (20)

1. B. Jereczek-Fossa, and R. Orecchia Evidence based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastasing prostate cancer Radiother Oncol 84 2007 197 215
2. A. Al-Mamgani, W.D. Heemsbergen, and P.C. Levendag Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial Radiother Oncol 96 2010 13 18
3. J. Michalsky, A. Jackson, and S.L. Tucker QUANTEC-quantitative analyses of normal tissue effects in the clinic Int J Radiat Oncol Biol Phys 76 2010 S123 S129
4. G.A. Viani, E.J. Stefano, and S.L. Alfonso Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials Int J Radiat Oncol Biol Phys 74 2009 1405 1418
5. L. Chen, C. Paskalev, and X. Xu Rectal dose variation during the course of image guided radiation therapy of prostate cancer Radiother Oncol 95 2010 198 202
6. S.L. Guliford, M. Patridge, and M.R. Sydes A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity Radiother Oncol 94 2010 241 247
7. J.A. Hatton, P.B. Greer, and C. Tang Does the planning dose-volume histogram represent treatment doses in image guided prostate radiation therapy? Assessment with cone-beam computerized tomography scans Radiother Oncol 98 2011 162 168
8. M. Saraoka, A. Nishikawa, and T. Futami Rectal dose reduction using three-dimensional conformal radiotherapy for locally advanced prostate cancer: a combination of conformal dynamic-arc and five static field technique Radiother Oncol 90 2009 318 324
9. T.J. Morancy, K.M. Winkfield, and C.A. Karasiewicz Use of a blood patch technique to reduce rectal dose during Cesium-131 prostate brachytherapy Int J Radiat Oncol Biol Phys 72 2008 S331 S332
10. R.C. Susil, T.R. McNutt, and T.L. DeWeese Effects of prostate-rectum separation on rectal dose from external beam radiotherapy Int J Radiat Oncol Biol Phys 76 2010 1251 1258
11. P.J. Prada, J. Fernandez, and A.A. Martinez Transperineal injection of hyalouronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients Int J Radiat Oncol Biol Phys 69 2007 95 102
12. R. Ben-Yosef, A. Paz, and Y. Levy A novel device for protecting rectum during prostate cancer irradiation: in vivo data on a large mammal model J Urol 181 2009 1401 1406
13. Y. Levy, A. Paz, and R. Ben-Yosef Biodegradable inflatable balloon for reducing radiation adverse effects in prostate cancer J Biomed Mater Res B Appl Biomater 91 2009 855 867
14. G. Kovács, G. Scarzello, and I. Koziol Significant rectal dose reduction during prostate cancer radiotherapy using novel biodegradable inflatable balloon system: interim results of a prospective multi-center study Int J Radiat Oncol Biol Phys 78 2010 S77
15. R. Pötter, C. Haie-Meder, and E. van Limbergen Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 2006 67 77
16. C. Salambier, P. Lavagnini, and P. Nickers Tumor and target volumes in permanent prostate brachytherapy: supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy Radiother Oncol 2007 10.1016/j.radonc.2007.01014
17. M. Pinkawa, N.E. Corral, and M. Caffaro Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer Radiother Oncol 100 2011 436 441
18. C. Lütgendorf-Caucig, I. Fotina, and M. Stock Feasibility of CBTC-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study Radiother Oncol 98 2011 154 161
19. M. Pinkawa, M.D. Piroth, and R. Holyet Al: quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis Strahlenther Onkol 188 2012 917 925
20. K. Kishi, M. Sato, and S. Shirai Reirradiation of prostate cancer with rectum preservation: eradicative high-dose-rate brachytherapy with natural type hyaluronate injection Brachytherapy 11 2012 144 148